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Volume 54, Number 2 Abstracts 595or postoperative complications. The mean follow-up was 372 days. Six
patients required additional TASMR. Two patients underwent contralat-
eral TAFRR for neurogenic TOS. Overall, 18 patients had either com-
plete resolution or minimal residual symptoms. All patients were able to
return to school and 92% (11/12) of athletes were able to return to
competition.
Conclusions: Surgical treatment of neurogenic TOS in adolescents
may be performed with low morbidity. The majority of patients are female
and anatomic anomalies are commonly identified. Almost one third of
patients may require additional TASMR. Significant improvement in symp-
toms, the ability to return to school, and resumption of athletic competition
suggests that, in carefully selected adolescent patients, results may be supe-
rior to those reported in adults.
Hospital Volume of Thoracoabdominal Aneurysm Repair Does Not
Affect Mortality in California
Anna C. Weiss, MD, Amanda Green, Katherine E. Brown, MD, David
Chang, PhD, and Nikhil Kansal, MD, General Surgery, University of
California – San Diego, San Diego, Calif.
Objective: Current literature has shown that high volume institutions
have better outcomes after thoracoabdominal aneurysm repairs (TAARs).
The objective of this study was to investigate the morbidity and mortality
rates of TAAR in California. We hypothesized that the morbidity and
mortality rates have improved over the last 15 years, and that higher volume
institutions have significantly better outcomes.
Methods: We queried the California 100% discharge database for
patients who underwent TAAR between 1995 and 2008. We performed a
retrospective review comparing morbidity and mortality rates each year.
Morbidities included paraplegia, myocardial infarction, stroke, respiratory
failure, and renal failure. Two methods of classifying hospitals into low and
high volume cohorts were used: volume each year, or 3-year averages to
account for fluctuations. High volume was defined as more than eight
TAARs per year. An adjusted analysis was performed correcting for the
patient demographics, Charlson index, aneurysm rupture, and elective re-
pair.
Results: There were a total of 1085 TAARs between 1995 and 2008.
There were 117 low volume and four high-volume institutions. The mor-
bidity and mortality rates after TAAR did not significantly improve over time
(P  .3 and .25, respectively). On unadjusted analysis, the mortality rate at
1-year low volume institutions was 27%, compared to 20% at 1-year high-
volume institutions (P  .02). The mortality rate at 3-year averaged high-
volume institutions was 23%, compared to 25% at low-volume (P  .353).
Adjusted analysis revealed an odds ratio of mortality of 0.385 at 1-year
high-volume institutions (P  .053, 95% confidence interval [CI], .35-
1.01). Three-year averaged high-volume hospitals had an odds ratio of
mortality of 0.59 (P  .396; 95% CI, .175-1.99).
Conclusions: The morbidity and mortality rates after TAAR have not
significantly changed over the past 15 years in California. Although current
literature reports significantly better outcomes after TAAR at high-volume
institutions, in the state of California, the mortality after TAAR is similar at
both low-volume and high-volume institutions.
Optimal Method of Obtaining Aortic Measurements for Endovascular
Aneurysm Repair
Marlin Causey, Reagan Quan, Thomas Curry, and Niten Singh, Department
of Surgery Residency, Madigan Army Medical Center, Ft. Lewis, Wash.
Objective: Accurate preoperative planning and sizing for endovascular
aneurysm repair (EVAR) is essential for reduced procedural time, more
efficient utilization of fluoroscopy and contrast, and prevention of latter
adjunctive procedures. The current preoperative standard for EVAR is axial
computed tomography (CT), but other imaging modalities such as intravas-
cular ultrasound (IVUS), angiography, and CT reconstruction software
packages have also been used. Our objective was to determine which of the
above-mentioned imaging modalities is the optimal method of preoperative
planning for EVAR.
Methods: Data was collected prospectively over a 10-month period of
time on consecutive patients undergoing EVAR. Preoperatively, the sur-
geon of record obtained his measurements and calculations utilizing a
CT-reconstruction software package (RS Software) with centerline measure-
ments. Another surgeon, blinded to the case, obtained measurements and
calculations using standard axial CT. A standardized measurement protocol
was used. Both surgeons chose endografts based on their individual mea-
surements. Intraoperatively, IVUS and angiographic measurements were
obtained in a nonblinded fashion.
Results: Twenty EVARs were performed during the study period (3
women and 17 men) with a mean age of 72  5.5 years using an average
of 94.5 mL of contrast and 22 minutes of fluoroscopy. Aortic measure-
ments are listed in Table I comparing the different modalities. There was
no statistically significant difference in diameter measurement between
different modalities. However, centerline measurements from the RS
o
Pere significantly longer than either the CT or IVUS lengths and did
orrelate with the actual length and ultimately the graft used (Table II).
he ultimate endograft chosen correlated with the endograft in the RS
oftware in 15 of 17 patients while only 1 of 3 was sized appropriately
rom axial CT.
Conclusions: The ideal method to measure the aorta before deploy-
ent of an abdominal aortic endograft is evolving as technology im-
roves. We believe using reconstructive software of axial CTs allows for
ore accurate preoperative planning, particularly with the length of
rafts chosen.
able I. EVAR diameters at different levels
evel CT (mm) M2S (mm) IVUS (mm) P value
enal arteries 23.7  0.9 23.8  0.8 22.8  0.7 .731
mm 24.1  0.9 24.5  1.1 .986
0 mm 24.2  0.9 25.8  1.2 24.9  1.2 .921
5 mm 25.9  1.0 26.4  1.2 .811
0 mm 26.9  0.8 27.2  1.2 26.3  1.2 .812
ifurcation 23.0  1.1 24.9  1.7 22.8  1.5 .822
CIA seal 12.8  0.7 13.7  0.6 12.0  0.6 .272
CIA seal 13.0  0.8 12.3  0.4 11.7  0.6 .413
T, Computed tomography; IVUS, intravascular ultrasound; L CIA, left
ommon iliac artery; R CIA, right common iliac artery.
able II. Centerline measurements comparing different
odalities
enterline





orta to bifurcation 104  3.3 103  9.5 102  7.5 .812
orta to left
hypogastric 160  4.7 184  6.1 156  9.8 .019
orta to right
hypogastric 161  4.0 183  7.0 160  9.3 .012
T, Computed tomography.
ignificant Clinical Predictors of Postoperative Mortality Following
ndovascular Abdominal Aortic Aneurysm Repair
han-Vu Nguyen, MD, Linda Chun, MD, Clarence W. Cole, MD, and
evin Patel, MD, Kaiser Permanente-Los Angeles Medical Center, Los
ngeles, Calif.
Objectives: The purpose of this study was to show the relationships
etween endovascular aneurysm repair and the causes for long-term
ostoperative death in order to identify significant predictors of mortal-
ty.
Methods: A retrospective review of a multi-institution database of all
atients that underwent EVAR between May 2003 and June 2010 was
erformed. Comparisons of patient demographics and clinical characteristics
etween deceased and alive patients were evaluated.
Results: Five hundred eighty-eight patients (68 women and 520 men)
nderwent EVAR during the study period. There were a total of 82 deaths
13.9%). The causes of death were distributed as follows: 12 (14.6%), 6
7.3%), 25 (30.5%), 3 (3.7%), 7 (8.5%), and 29 (35.4%) in pulmonary,
ardiac, cancer, postoperation, other, and unknown, respectively. The aver-
ge age of patients was 77.8 7.8 years for those who died and 73.9 8.1
ears for those who were alive. Adjusting for all the other variables in the
odels, for each year increase in age, there was an 8% increase risk of death.
n addition, positive and significant relationships were found between age,
nd-stage renal disease (ESRD), chronic obstructive pulmonary disease
COPD), postoperative pulmonary event, and risk of all cause mortality.
atients with ESRD or COPD had approximately 4 and 2 times higher risk
f death compared to those without ESRD and COPD. There was a
rotective relationship between the patients on acetylsalicylic acid (ASA) or
reoperative statin and risk of all cause mortality. Those on an ASA or statin
efore operation were 50% and 46% less likely to die than those patients who
id not.
Conclusions: Patient age at time of EVAR and the presence of ESRD
r COPD were significant risk factors for long-term post repair mortality.
erioperative ASA and statin use were protective.
